Aclaris Therapeutics (NASDAQ:ACRS) Downgraded by StockNews.com to “Sell”
StockNews.com cut shares of Aclaris Therapeutics (NASDAQ:ACRS – Free Report) from a hold rating to a sell rating in a report published on Saturday. Several other equities research analysts have also commented on the stock. BTIG Research raised shares of Aclaris Therapeutics from a “neutral” rating to a “buy” rating and set a $8.00 price […]
StockNews.com cut shares of Aclaris Therapeutics (NASDAQ:ACRS – Free Report) from a hold rating to a sell rating in a report published on Saturday. Several other equities research analysts have also commented on the stock. BTIG Research raised shares of Aclaris Therapeutics from a “neutral” rating to a “buy” rating and set a $8.00 price […]
